CRISPR Therapeutics AG
CRSP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $286,497 | $197,132 | $235,184 | $298,257 |
| Short-Term Investments | $1,629,213 | $1,527,619 | $1,620,101 | $1,605,569 |
| Receivables | $0 | $0 | $0 | $25,000 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $13,382 | $8,915 | $12,326 | $8,306 |
| Total Curr. Assets | $1,929,092 | $1,733,666 | $1,867,611 | $1,937,132 |
| Property Plant & Equip (Net) | $255,490 | $262,567 | $269,703 | $277,554 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $28,412 | $30,606 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $32,314 | $2,872 | $28,788 | $27,348 |
| Total NC Assets | $316,216 | $296,045 | $298,491 | $304,902 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,245,308 | $2,029,711 | $2,166,102 | $2,242,034 |
| Liabilities | – | – | – | – |
| Payables | $11,798 | $9,753 | $13,064 | $14,709 |
| Short-Term Debt | $18,256 | $18,027 | $17,506 | $17,288 |
| Tax Payable | $3,426 | $715 | $1,241 | $451 |
| Deferred Revenue | $1,295 | $2,129 | $3,021 | $3,845 |
| Other Curr. Liab. | $84,182 | $73,738 | $84,615 | $51,489 |
| Total Curr. Liab. | $118,957 | $104,362 | $119,447 | $87,782 |
| LT Debt | $192,768 | $197,425 | $201,852 | $206,405 |
| Deferred Rev, NC | $12,323 | $12,323 | $12,323 | $12,323 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $5,278 | $4,476 | $3,320 | $3,444 |
| Total NC Liab. | $210,369 | $214,224 | $217,495 | $222,172 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $192,768 | $197,425 | $201,852 | $206,405 |
| Total Liabilities | $329,326 | $318,586 | $336,942 | $309,954 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3,013 | $2,794 | $2,721 | $2,698 |
| Retained Earnings | -$1,816,938 | -$1,710,497 | -$1,501,948 | -$1,365,952 |
| AOCI | $4,986 | $4,041 | $4,135 | $1,840 |
| Other Equity | $3,724,921 | $3,414,787 | $3,324,252 | $3,293,494 |
| Total Equity | $1,915,982 | $1,711,125 | $1,829,160 | $1,932,080 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,245,308 | $2,029,711 | $2,166,102 | $2,242,034 |
| Net Debt | -$75,473 | $18,320 | -$15,826 | -$74,564 |